These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2434194)

  • 1. Nigrostriatal dopamine neurons receive substance P-ergic inputs in the substantia nigra: application of the immunoelectron microscopic mirror technique to fluorescent double-staining for transmitter-specific projections.
    Kawai Y; Takagi H; Kumoi Y; Shiosaka S; Tohyama M
    Brain Res; 1987 Jan; 401(2):371-6. PubMed ID: 2434194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: an ultrastructural double-labeling immunocytochemical study.
    Mendez I; Elisevich K; Flumerfelt B
    J Comp Neurol; 1991 Jun; 308(1):66-78. PubMed ID: 1714923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat.
    Bolam JP; Smith Y
    Brain Res; 1990 Oct; 529(1-2):57-78. PubMed ID: 1704287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal substance P cell clusters coincide with the high density terminal zones of the discontinuous nigrostriatal dopaminergic projection system in the cat: a study by combined immunohistochemistry and autoradiographic axon-tracing.
    Beckstead RM
    Neuroscience; 1987 Feb; 20(2):557-76. PubMed ID: 2438592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct demonstration of interactions between substance P immunoreactive terminals and tyrosine hydroxylase immunoreactive neurons in the substantia nigra of the rat: an ultrastructural study.
    Mahalik TJ
    Synapse; 1988; 2(5):508-15. PubMed ID: 2460962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single dopaminergic nigrostriatal neurons form two chemically distinct synaptic types: possible transmitter segregation within neurons.
    Hattori T; Takada M; Moriizumi T; Van der Kooy D
    J Comp Neurol; 1991 Jul; 309(3):391-401. PubMed ID: 1717519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra.
    Cruz CJ; Beckstead RM
    Neuroscience; 1989; 30(2):331-8. PubMed ID: 2473415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neostriatal cholinergic neurons receive direct synaptic inputs from dopaminergic axons.
    Kubota Y; Inagaki S; Shimada S; Kito S; Eckenstein F; Tohyama M
    Brain Res; 1987 Jun; 413(1):179-84. PubMed ID: 2885073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic nicotine treatment differentially regulates substance P and tyrosine hydroxylase immunoreactivity in substantia nigra ipsilateral to a unilateral lesion.
    Janson AM; Fuxe K
    Exp Neurol; 1997 Aug; 146(2):575-86. PubMed ID: 9270071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host neostriatum.
    Bolam JP; Freund TF; Björklund A; Dunnett SB; Smith AD
    Exp Brain Res; 1987; 68(1):131-46. PubMed ID: 2446902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P-dopamine relationship in the rat substantia nigra: a light and electron microscopy study of double immunocytochemically labeled materials.
    Chang HT
    Brain Res; 1988 May; 448(2):391-6. PubMed ID: 2454145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P synaptic interactions with GABAergic and dopaminergic neurons in rat substantia nigra: an ultrastructural double-labeling immunocytochemical study.
    Mendez I; Elisevich K; Flumerfelt B
    Brain Res Bull; 1992 Apr; 28(4):557-63. PubMed ID: 1377584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic interaction between catecholaminergic neurons and substance P-immunoreactive axons in the caudal part of the nucleus of the solitary tract of the rat: demonstration by the electron microscopic mirror technique.
    Kubota Y; Takagi H; Morishima Y; Powell JF; Smith AD
    Brain Res; 1985 Apr; 333(1):188-92. PubMed ID: 2581657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic localization of substance P degradative enzymes(s) in rat substantia nigra.
    Quik M; Emson PC
    Neurosci Lett; 1979 Dec; 15(2-3):217-22. PubMed ID: 93730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
    Hersch SM; Yi H; Heilman CJ; Edwards RH; Levey AI
    J Comp Neurol; 1997 Nov; 388(2):211-27. PubMed ID: 9368838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the presence of dopaminergic neurons and GABA receptors in substantia nigra: effects of lesions.
    Gale K
    Brain Res; 1981 Apr; 210(1-2):401-6. PubMed ID: 6112044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-containing neurons of the substantia nigra and their terminals in the neostriatum.
    Tennyson VM; Mytilineou C; Heikkila R; Barrett RE; Cohen G; Côté L; Duffy PE; Marco L
    UCLA Forum Med Sci; 1975; (18):227-64. PubMed ID: 827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y-immunoreactive neurons receive synaptic inputs from dopaminergic axon terminals in the rat neostriatum.
    Kubota Y; Inagaki S; Kito S; Shimada S; Okayama T; Hatanaka H; Pelletier G; Takagi H; Tohyama M
    Brain Res; 1988 Aug; 458(2):389-93. PubMed ID: 2905200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra.
    Lévesque M; Wallman MJ; Parent R; Sík A; Parent A
    Neurosci Res; 2007 Mar; 57(3):362-71. PubMed ID: 17134780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separate neuronal populations of the rat substantia nigra pars lateralis with distinct projection sites and transmitter phenotypes.
    Moriizumi T; Leduc-Cross B; Wu JY; Hattori T
    Neuroscience; 1992; 46(3):711-20. PubMed ID: 1372117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.